Cite
Yasumatsu R, Shimizu Y, Hanai N, et al. Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. Int J Clin Oncol. 2021;27(1):95-104doi: 10.1007/s10147-021-02047-y.
Yasumatsu, R., Shimizu, Y., Hanai, N., Kariya, S., Yokota, T., Fujii, T., Tsukahara, K., Ando, M., Hanyu, K., Ueda, T., Hirakawa, H., Takahashi, S., Ono, T., Sano, D., Yamauchi, M., Watanabe, A., Omori, K., Yamazaki, T., Monden, N., Kudo, N., Arai, M., Yonekura, S., Asakage, T., Nekado, T., Yamada, T., & Homma, A. (2022). Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. International journal of clinical oncology, 27(1), 95-104. https://doi.org/10.1007/s10147-021-02047-y
Yasumatsu, Ryuji, et al. "Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study." International journal of clinical oncology vol. 27,1 (2022): 95-104. doi: https://doi.org/10.1007/s10147-021-02047-y
Yasumatsu R, Shimizu Y, Hanai N, Kariya S, Yokota T, Fujii T, Tsukahara K, Ando M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Nekado T, Yamada T, Homma A. Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study. Int J Clin Oncol. 2022 Jan;27(1):95-104. doi: 10.1007/s10147-021-02047-y. Epub 2021 Nov 13. PMID: 34773525.
Copy
Download .nbib